Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Remy International Inc (REMY)’s Move

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and “initiating coverage at neutral.” Today, we’ll show you whether those bigwigs actually know what they’re talking about. To help, we’ve enlisted Motley Fool CAPS to track the long-term performance of Wall Street’s best and worst.

B. Riley, “A” for effort
Today we’ll be looking at a small-cap industrialist that just caught an upgrade from the analysts at B. Riley & Co.: Remy International Inc (NASDAQ:REMY). Remy International Inc (NASDAQ:REMY)’s an interesting little company, a remainder of the old Delco Remy division of General Motors Company (NYSE:GM), and now majority-owned by Fidelity National Financial Inc (NYSE:FNF). Based in Pendleton, Ind., it manufactures and sells primarily electrical components for automobiles, light trucks, tractor-trailers, and other vehicles.

The company last reported earnings earlier this month, on May 1, and the news wasn’t good. Q1 2013 sales slipped 4% against the year-ago quarter. Earnings plunged 85% (largely because of severance benefits paid when CEO John Weber stepped down back in February), leaving the company with barely $0.04 in per-share profit earned, versus $0.28 the company had earned in last year’s Q1. Regardless, B. Riley resumed coverage of Remy on Friday with a buy rating and a $23 price target.

But does Remy International Inc (NASDAQ:REMY) deserve it?

First, a word from our sponsor …
I actually think the answer to this one could be “yes.” But before I tell you why, let me make one quick disclosure right up front: My wife works for Remy International Inc (NASDAQ:REMY). She doesn’t own stock in the company (although I admit — one motivation I have in writing up this Remy rating is to decide how I’ll answer her if she’s offered stock options at some point and asks me whether she should take advantage of them). But she does draw a paycheck.

Anyway — while I don’t think this employment relationship is affecting my evaluation of the company, I could be wrong, and you should be able to factor this possible bias into how you read the rest of this article. That’s part and parcel with the Motley Fool disclosure policy.

Now let’s get back to B. Riley, and its endorsement of Remy International Inc (NASDAQ:REMY).

Let’s go to the tape
One of the better-ranked analysts we follow here on Motley Fool CAPS, B. Riley has a strong record of picking strong stocks for its customers. It ranks, in fact, in the top 5% of analysts we track. This broker boasts 57% accuracy on its picks over the past few years, with its average stock recommendation outpacing the S&P 500’s returns by more than 12 percentage points. As such, a B. Riley endorsement of Remy should not be taken lightly.

As for the stock it’s endorsing, Remy International Inc (NASDAQ:REMY) has some pretty impressive numbers, too. Its poor performance in Q1 notwithstanding, cumulative earnings for the past 12 months still come to $131 million — giving the stock a temptingly low P/E ratio of just 4.3.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.